| Autor: |
Zeng, Qing, Machado, Michael, Bie, Chongxue, van Zijl, Peter C. M., Malvar, Sofi, Li, Yuguo, D'souza, Valentina, Poon, Kirsten Achilles, Grimm, Andrew, Yadav, Nirbhay N. |
| Předmět: |
|
| Zdroj: |
Magnetic Resonance in Medicine; Mar2024, Vol. 91 Issue 3, p1115-1121, 7p |
| Abstrakt: |
Purpose: Glycogen storage disease type III (GSD III) is a rare inherited metabolic disease characterized by excessive accumulation of glycogen in liver, skeletal muscle, and heart. Currently, there are no widely available noninvasive methods to assess tissue glycogen levels and disease load. Here, we use glycogen nuclear Overhauser effect (glycoNOE) MRI to quantify hepatic glycogen levels in a mouse model of GSD III. Methods: Agl knockout mice (n = 13) and wild‐type controls (n = 10) were scanned for liver glycogen content using glycoNOE MRI. All mice were fasted for 12 to 16 h before MRI scans. GlycoNOE signal was quantified by fitting the Z‐spectrum using a four‐pool Voigt lineshape model. Next, the fitted direct water saturation pool was removed and glycoNOE signal was estimated from the integral of the residual Z spectrum within −0.6 to −1.4 ppm. Glycogen concentration was also measured ex vivo using a biochemical assay. Results: GlycoNOE MRI clearly distinguished Agl knockout mice from wild‐type controls, showing a statistically significant difference in glycoNOE signals in the livers across genotypes. There was a linear correlation between glycoNOE signal and glycogen concentration determined by the biochemical assay. The obtained glycoNOE maps of mouse livers also showed higher glycogen levels in Agl knockout mice compared to wild‐type mice. Conclusion: GlycoNOE MRI was used successfully as a noninvasive method to detect liver glycogen levels in mice, suggesting the potential of this method to be applied to assess glycogen storage diseases. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
Plný text